EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The role of molecular diagnostic testing for hemoglobinopathies and thalassemias

Daniel E Sabath iD

International Journal of Laboratory Hematology · 2023-06 · 45 (S2) · 71-78

DOI: 10.1111/ijlh.14089 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Laboratory Hematology, online erschienen am 21.05.2023. Verfasst von Daniel E Sabath. Beteiligte Einrichtung: Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA. Hauptthemen laut MEDLINE: beta-Thalassemia, Hemoglobinopathies, alpha-Thalassemia. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 49 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hemoglobin disorders are among the most common genetic diseases worldwide. Molecular diagnosis is helpful in cases where the diagnosis is uncertain and for genetic counseling. Protein‐based diagnostic techniques are frequently adequate for initial diagnosis. Molecular genetic testing is pursued in some cases, particularly when a definitive diagnosis is not possible and especially for the purpose of assessing genetic risk for couples wanting to have children. The expertise available in the clinical hematology laboratory is essential for the diagnosis of patients with hemoglobin abnormalities. Initial diagnoses are made using protein‐based techniques such as electrophoresis and chromatography. Based on these findings, genetic risk to an individual's offspring can be assessed. In the setting of β‐thalassemia and other β‐globin disorders, coincident α‐thalassemia may be difficult to diagnose, which can have potentially serious consequences. In addition, unusual forms of β‐thalassemia caused by deletions in the β‐globin locus cannot be definitively characterized using standard techniques. Molecular diagnostic testing has an important role in the diagnosis of hemoglobin disorders and is important in the setting of genetic counseling. Molecular testing also has a role in prenatal diagnosis to identify fetuses affected by severe hemoglobinopathies and thalassemias.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-ThalassemiaHemoglobinopathiesalpha-ThalassemiaPregnancyFemaleChildHumansPrenatal DiagnosisMolecular Diagnostic Techniquesbeta-Globins

Stichwörter der Autor:innen

genetic counselinghemoglobinopathymolecular diagnosisthalassemia

Substanzen

beta-Globins

Autor:innen und Institutionen

  • Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.

ORCID-Profile: Daniel E Sabath

Zitieren

APA

Sabath, D. E. (2023). The role of molecular diagnostic testing for hemoglobinopathies and thalassemias. International Journal of Laboratory Hematology, 45(S2), 71-78. https://doi.org/10.1111/ijlh.14089

Vancouver

Sabath DE. The role of molecular diagnostic testing for hemoglobinopathies and thalassemias. International Journal of Laboratory Hematology. 2023;45(S2):71-78. doi:10.1111/ijlh.14089

BibTeX
@article{Sabath2023,
  author = {Sabath, Daniel E},
  title = {The role of molecular diagnostic testing for hemoglobinopathies and thalassemias},
  journal = {International Journal of Laboratory Hematology},
  year = {2023},
  volume = {45},
  number = {S2},
  pages = {71--78},
  doi = {10.1111/ijlh.14089}
}
Kostenlos starten →